Prognostic Value of PCNA and Mutant p53 Expression in Laryngeal Squamous Cell Carcinoma

The objective of this study was to investigate the prognostic significance of p53, and proliferative cell nuclear antigen (PCNA) in laryngeal squamous cell carcinoma (LSCC). Sixty pathologic specimens from the patients with LSCC were examined for the expression of the p53 and PCNA, with complete follow-up data. Sixty-three percent of the cases displayed nuclear p53 overexpression. There was a correlation between p53 overexpression and histological grades (p = 0.03), and localization site (p = 0.05). Median of PCNA index was 42.2 (range 5.9 to 85.2). There was no difference between the p53 overexpression group and the normal group in proliferative activity determined by PCNA (p = 0.73). In univariate analyses, localization site, grade, stage, invasion pattern, lymph node status, were significant factors in estimating disease free survival (DFS). Grade was the most important factor affecting recurrence (p = 0.002). In multivariate analyses, grade was the only significant predictor for DFS (p = 0.001). Grade (p = 0.001) and invasion pattern (p = 0.03) were found to be significant predictors of overall survival. In conclusion, the histological grade was the most reliable important prognostic factor. Further studies are necessary to facilitate understanding of the mechanisms of laryngeal carcinogenesis.

[1]  K. Hemminki,et al.  Alteration of p53 gene structure and function in laryngeal squamous cell cancer , 2006, European Archives of Oto-Rhino-Laryngology.

[2]  H. VallésVarela,et al.  Immunohistochemical markers of cell proliferation in laryngeal carcinoma , 2000 .

[3]  J. Valencia Julve,et al.  [Immunohistochemical markers of cell proliferation in laryngeal carcinoma]. , 2000, Acta otorrinolaringologica espanola.

[4]  G. Gedıkoğlu,et al.  Prognostic significance of histopathological parameters in cancer of the larynx , 1999, European Archives of Oto-Rhino-Laryngology.

[5]  J. Ryś,et al.  The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx. , 1998, Auris, nasus, larynx.

[6]  A. El‐Naggar,et al.  The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl‐2 in laryngeal squamous cell carcinoma , 1998, Cancer.

[7]  W. Golusiñski,et al.  Retrospektive Analyse ausgewählter Tumormarker (p53, PCNA, Ki67; DNA-Ploidie) und der Ultrastruktur bei Kranken mit Larynxkarzinomen , 1998, HNO.

[8]  J. Olofsson,et al.  [Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas]. , 1998, HNO.

[9]  V. Kosma,et al.  p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Fukushima,et al.  Prognostic significance of the MIB‐1 proliferation index for patients with squamous cell carcinoma of the esophagus , 1995, Cancer.

[11]  H. Dienes,et al.  Predicting Recurrence and Survival in Patients with Laryngeal Cancer by Means of DNA Cytometry, Tumor Front Grading, and Proliferation Markers , 1995, The Annals of otology, rhinology, and laryngology.

[12]  S. Syrjänen,et al.  Implications of the p53 tumor-suppressor gene in clinical oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Armand,et al.  High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. , 1995, Oncogene.

[14]  E. Campo,et al.  p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors , 1995, The Journal of pathology.

[15]  P. Bradley,et al.  Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. , 1994, American journal of surgery.

[16]  G. Dardanoni,et al.  P53 expression in stage iii-iv squamous-cell carcinoma of the larynx - an immunohistochemical study related to clinicopathological, flow-cytometric DNA analysis and prognosis. , 1994, International journal of oncology.

[17]  A. Cuschieri,et al.  The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. , 1994, British Journal of Cancer.

[18]  A. Malliri,et al.  P53 expression in end-stage squamous-cell carcinoma of the head and neck prior to chemotherapy treatment - expression correlates with a very poor clinical outcome. , 1993, International journal of oncology.

[19]  Hannu,et al.  Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. , 1993, The American journal of pathology.

[20]  H. Sasano,et al.  Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. , 1992, Human pathology.

[21]  R. Maestro,et al.  p53 over‐expression is an early event in the development of human squamous‐cell carcinoma of the larynx: Genetic and prognostic implications , 1992, International journal of cancer.

[22]  J Vasko,et al.  Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  R. Maestro,et al.  High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. , 1992, Oncogene.

[24]  F. Demard,et al.  The labelling index: a prognostic factor in head and neck carcinoma. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  A. Levine,et al.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.

[26]  C. Muir,et al.  Estimates of the worldwide frequency of twelve major cancers. , 1984, Bulletin of the World Health Organization.